On Wednesday August 21, 2024, Alvotech filed a preliminary prospectus on form F-3 with the U.S. Securities and Exchange Commission (SEC). Alvotech filed this preliminary prospectus with the SEC to fulfill contractual obligations with an existing shareholder, Morgan Stanley & Co. (the „shareholder“). If the registration statement is approved by the SEC and becomes effective, the shareholder may offer and sell its 1,789,087 ordinary shares in Alvotech. This does not indicate that the shareholder intends to offer or sell the shares. The shares are included in the total number of outstanding shares in Alvotech, which were 301,481,596 as of July 1, 2024.
The form F-3 is attached.
Alvotech Investor Relations
Benedikt Stefansson, VP
alvotech.ir@alvotech.com
Attachment
